Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Third Culture Capital (3CC) is an immigrant-founded, physician-led, seed-stage venture capital firm whose mission is to advance equity and diversity in healthcare innovation. 3CC prioritizes early-stage investments in "Third Culture entrepreneurs" whose unique perspectives have the potential to help transform healthcare and address health disparities by optimizing care delivery in healthtech and biotech. The firm invests in global-minded future leaders who combine ingenuity with sound business practices to innovate within established markets. They focus on early-stage companies in the healthcare sector that combine technology and biology, with a check size range of $250,000 to $1 million, targeting pre-seed, seed, and seed-plus stages.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Third Culture Capital's (3CC) primary investment focus by sector?
- Third Culture Capital (3CC) has shown a focus on the Health Tech & Life Sciences sector, with one portfolio company in this area.
- Can you name a notable company in Third Culture Capital's (3CC) portfolio?
- Voiceitt, a company specializing in voice recognition technology for non-standard speech, is a notable company in Third Culture Capital's (3CC) portfolio. Voiceitt raised a $22.05M Series A round.
- When did Third Culture Capital (3CC) make its most recent recorded investment?
- Third Culture Capital (3CC) made its most recent recorded investment in December 2022.
- What is the typical investment range for Third Culture Capital (3CC)?
- Third Culture Capital (3CC)'s investment range is between $4.7M and $4.7M.
- How many new portfolio companies did Third Culture Capital (3CC) add in 2022?
- Third Culture Capital (3CC) added one new portfolio company in December 2022.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2021 |
|---|